法布雷病临床试验招募信息（全球在招）
这里汇总了全球正在招募患者的 法布雷病（国际通用名 Fabry disease）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。
正在招募的法布雷病新药试验
Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes
不适用招募中意大利NCT07382128Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
I 期 / II 期招募中美国NCT06270316Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI
不适用招募中加拿大NCT04856059Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
不适用招募中美国德国意大利西班牙NCT06941025Fabry Disease Registry & Pregnancy Sub-registry
不适用招募中美国Argentina澳大利亚BelgiumNCT00196742Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment
不适用招募中法国NCT07277361A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
II 期 / III 期招募中美国Austria法国NorwayNCT06328608Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease
不适用招募中中国NCT06539624Evaluation of the Safety, Tolerability and Efficacy of a Gene Therapy Drug for the Treatment of Pediatric Fabry Disease
早期 I 期招募中中国NCT06207552National Registry of Rare Kidney Diseases
不适用招募中英国NCT06065852Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational Study
不适用招募中德国NCT06758648Evaluation of HEArt invoLvement in Patients With FABRY Disease
不适用招募中德国NCT03362164
法布雷病试验不在中国大陆，还能参加吗？
可以尝试四条现实路径：查找国内同类试验、申请同情用药与扩展准入、赴境外研究中心入组、直接写信给申办方申请在华开展。本站提供中英文对照的咨询信模板，患者和家属填写基本情况即可生成。